Malgorzata Rogalska, PhD is an Analyst at Ysios Capital, where she identifies and evaluates investment opportunities in life sciences. She holds a PhD in Human Genetics and brings over 15 years of experience in RNA therapeutics and gene regulation across genetic diseases, oncology, and metabolic disorders. Malgorzata combines deep scientific expertise with financial analysis to support strategic investments in innovative health technologies. Prior to joining Ysios, she was a senior researcher and has authored numerous high-impact publications, including in Nature and Science.